Research Papers:

miR-193b and miR-30c-1* inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro

Theresa Kordaß, Claudia E.M. Weber, David Eisel, Antonino A. Pane, Wolfram Osen and Stefan B. Eichmüller _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2018; 9:32507-32522. https://doi.org/10.18632/oncotarget.25986

Metrics: PDF 1355 views  |   HTML 3325 views  |   ?  


Theresa Kordaß1,2, Claudia E.M. Weber1, David Eisel1,2, Antonino A. Pane1,2, Wolfram Osen1 and Stefan B. Eichmüller1

1GMP and T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany

2Faculty of Biosciences, University Heidelberg, Heidelberg, Germany

Correspondence to:

Stefan B. Eichmüller, email: [email protected]

Keywords: melanoma; miRNA; invasion; BCL9; MCL1

Received: May 02, 2018     Accepted: July 29, 2018     Published: August 21, 2018


In cancer cells, microRNAs (miRNAs) are often aberrantly expressed resulting in impaired mRNA translation. In this study we show that miR-193b and miR-30c-1* inhibit, whereas miR-576-5p accelerates invasion of various human melanoma cell lines. Using Boyden chamber invasion assays the effect of selected miRNAs on the invasive capacity of various human melanoma cell lines was analyzed. Upon gene expression profiling performed on transfected A375 cells, CTGF, THBS1, STMN1, BCL9, RAC1 and MCL1 were identified as potential targets. For target validation, qPCR, Western blot analyses or luciferase reporter assays were applied. This study reveals opposed effects of miR-193b / miR-30c-1* and miR-576-5p, respectively, on melanoma cell invasion and on expression of BCL9 and MCL1, possibly accounting for the contrasting invasive phenotypes observed in A375 cells transfected with these miRNAs. The miRNAs studied and their targets identified fit well into a model proposed by us explaining the regulation of invasion associated genes and the observed opposed phenotypes as a result of networked direct and indirect miRNA / target interactions. The results of this study suggest miR-193b and miR-30c-1* as tumor-suppressive miRNAs, whereas miR-576-5p appears as potential tumor-promoting oncomiR. Thus, miR-193b and miR-30c-1* mimics as well as antagomiRs directed against miR-576-5p might become useful tools in future therapy approaches against advanced melanoma.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25986